Douglas Jay Cohen - 27 Jan 2026 Form 4 Insider Report for VivoSim Labs, INC. (VIVS)

Role
Director
Signature
/s/ Norman Staskey, attorney-in-fact
Issuer symbol
VIVS
Transactions as of
27 Jan 2026
Net transactions value
$0
Form type
4
Filing time
29 Jan 2026, 19:59:37 UTC
Previous filing
09 Aug 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cohen Douglas Jay Director 11555 SORRENTO VALLEY ROAD, SUITE 100, SAN DIEGO /s/ Norman Staskey, attorney-in-fact 29 Jan 2026 0001824619

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIVS Common Stock Award $0 +15,000 +262% $0.000000 20,732 27 Jan 2026 Direct F1, F2
holding VIVS Common Stock 83 27 Jan 2026 By Son F2
holding VIVS Common Stock 83 27 Jan 2026 By Daughter F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units, which shall vest on the earlier of January 27, 2027 or the date of the next annual meeting of stockholders held by the Issuer, subject to acceleration in the event of a change of control.
F2 Effective on March 20, 2025, the Issuer conducted a reverse stock split of its common stock at a ratio of 1-for-12 (the "Reverse Split"). All share numbers reported herein give effect to the Reverse Split.

Remarks:

Exhibit 24 - Power of Attorney